Abstract:AbstractIntroductionMany clinical trials showed favorable effects of high-doses supplemental n-3 polyunsaturated fatty acids (PUFA) on cardio-metabolic risk factors. However, limited studies examined the prospective associations of circulating n-3 PUFA with body fat and its distribution, metabolic syndrome (MS), carotid atherosclerosis, and nonalcoholic fatty liver disease (NAFLD) in subjects with habitual diets containing low levels of n-3 PUFA.Materials and MethodsThis community-based prospective study enrolled 4048 participants (40–75 years) at baseline (2008–2010, 2013) from Guangzhou, China. They were followed-up approximately once every 3 years. Fatty acids in erythrocyte membranes were measured at baseline. We determined metabolic syndrome factors, body fat by DXA scanning, carotid intima-media thickness (IMT) and NAFLD by ultrasound at the visits. General information, anthropometric indices, habitual dietary intake and other covariates were assessed at each visit.ResultsAmong the total 4048 subjects, 3075 and 2671 subjects had erythrocyte n-3 PUFA data and completed the first and second follow-ups. Generally, erythrocyte n-3 PUFA were favorably associated with body fat (particularly at abdomen) and its changes, and with the presence and incidence of MS, type 2 diabetes, carotid IMT thickening. The participants with the highest (vs lowest) quartile of n-3 PUFA were associated with -5.81% fat mass (p < 0.001) and -2.11% of fat mass change at the abdomen (Android) area. The adjusted hazards ratios (95% CI) for the highest (vs. lowest) group were 0.74 (0.61, 0.89) (total n-3 PUFA), 0.71 (0.59, 0.86) (docosahexaenoic acid, DHA), 0.78 (0.65, 0.95) (docosapentaenoic acid, DPA), 1.96 (1.60, 2.40) (gamma-linolenic acid, GLA) for MS; 0.70(0.55, 0.90) (total n-3 PUFA), 0.67(0.52,0.87) (DHA) and 0.73(0.57,0.93) (DPA) for bifurcation IMT thickening, 0.57(0.38, 0.86) (eicosapentaenoic acid, EPA) and 0.63 (0.41, 0.95) (DPA) for type 2 diabetes, and 1.18 (1.09, 1.33) (DHA) for alleviated NAFLD. Both higher levels of total and individual marine n-3 PUFAs (DHA, EPA and DPA) were associated with lower blood pressure at baseline and lower changes in diastolic and systolic blood pressure over the follow-up period. Plant n-3 PUFA (α-linolenic acid, ALA) largely had less significant association with the above-mentioned indices as compared with marine n-3 PUFAs.DiscussionHigher proportions of erythrocyte n-3 PUFA (particularly marine sources) was associated with lower body fat, blood pressure and their changes, and lower risks of MS, type 2 diabetes and bifurcation IMT thickening, but higher chance of alleviated NAFLD in middle-aged and older adults.

The associations of erythrocyte membrane polyunsaturated fatty acids with skeletal muscle loss: A prospective cohort study

Erythrocyte Membrane Polyunsaturated Fatty Acids Are Associated with Incidence of Metabolic Syndrome in Middle-Aged and Elderly People–An 8.8-Year Prospective Study

Association of Erythrocyte N-3 Fatty Acids with DXA-body Fat and Cardio-Metabolic Indices in Middle-Aged and Elderly Adults: a Prospective Study

Effect of N-3 Polyunsaturated Fatty Acid Supplementation on Muscle Mass and Function with Aging: A Meta-Analysis of Randomized Controlled Trials✰

Higher Erythrocyte N-3 Polyunsaturated Fatty Acid Were Associated with a Better Profile of DXA-derived Body Fat and Fat Distribution in Adults.

Skeletal muscle mass indexes and nonalcoholic fatty liver disease in Chinese elders

Relationship between skeletal muscle mass with metabolic syndrome in Chinese elders

Independent association between serum C-peptide levels and fat mass-to-lean mass ratio in the aging process.

Effects of fish oil-derived n-3 polyunsaturated fatty acid on body composition, muscle strength and physical performance in older people: a secondary analysis of a randomised, double-blind, placebo-controlled trial

Polyunsaturated Fatty Acids and Their Relation with Bone and Muscle Health in Adults

Are dietary intake and nutritional status of specific polyunsaturated fatty acids correlated with sarcopenia outcomes in community-dwelling older adults with sarcopenia? - Exploratory results from ENHANce

Association of Erythrocyte N-3 Polyunsaturated Fatty Acids with Incident Type 2 Diabetes in a Chinese Population.

Association of Composite Dietary Antioxidant Index and Muscle Mass in Individuals with Metabolic Associated Fatty Liver Disease

Erythrocyte Membrane N-3 Polyunsaturated Fatty Acids Are Inversely Associated with the Presence and Progression of Nonalcoholic Fatty Liver Disease in Chinese Adults: a Prospective Study

Erythrocyte PUFAs, Circulating Acylcarnitines, and Metabolic Syndrome Risk: a Prospective Study in Chinese.

Higher Erythrocyte N–3 PUFAs Are Associated with Decreased Blood Pressure in Middle-Aged and Elderly Chinese Adults

Poor Vitamin D Status is Prospectively Associated with Greater Muscle Mass Loss in Middle-Aged and Elderly Chinese Individuals.

Influence of omega-3 fatty acids on skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults

Predictive value of percentage body fat in aging people with low muscle mass: A 2.2-year longitudinal study.

Long-chain n -3 polyunsaturated fatty acids for the management of age- and disease-related declines in skeletal muscle mass, strength and physical function

Plasma omega-3 polyunsaturated fatty acid and tocopherol statuses and their relationships with aging-related diseases